Hence, these above-mentioned results imply that the abnormal overexpression of ARDB2 and SRPK1 could promotes the malignant phenotype of soft tissue sarcoma cells, further validating our bioinformatic analysis results. Here, SRPK1 is linked to soft tissue sarcoma.